JP2014122923A5 - - Google Patents

Download PDF

Info

Publication number
JP2014122923A5
JP2014122923A5 JP2014071111A JP2014071111A JP2014122923A5 JP 2014122923 A5 JP2014122923 A5 JP 2014122923A5 JP 2014071111 A JP2014071111 A JP 2014071111A JP 2014071111 A JP2014071111 A JP 2014071111A JP 2014122923 A5 JP2014122923 A5 JP 2014122923A5
Authority
JP
Japan
Prior art keywords
patient
ctnt
ctni
treatment regimen
heart tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014071111A
Other languages
English (en)
Japanese (ja)
Other versions
JP5998171B2 (ja
JP2014122923A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014122923A publication Critical patent/JP2014122923A/ja
Publication of JP2014122923A5 publication Critical patent/JP2014122923A5/ja
Application granted granted Critical
Publication of JP5998171B2 publication Critical patent/JP5998171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014071111A 2007-05-10 2014-03-31 心臓障害を検出するための方法 Expired - Fee Related JP5998171B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92854107P 2007-05-10 2007-05-10
US60/928,541 2007-05-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010507486A Division JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016166494A Division JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法

Publications (3)

Publication Number Publication Date
JP2014122923A JP2014122923A (ja) 2014-07-03
JP2014122923A5 true JP2014122923A5 (https=) 2015-03-12
JP5998171B2 JP5998171B2 (ja) 2016-09-28

Family

ID=40002559

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2010507486A Expired - Fee Related JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法
JP2014071111A Expired - Fee Related JP5998171B2 (ja) 2007-05-10 2014-03-31 心臓障害を検出するための方法
JP2016166494A Expired - Fee Related JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法
JP2018193389A Withdrawn JP2019010123A (ja) 2007-05-10 2018-10-12 心臓障害を検出するための方法
JP2020122926A Expired - Fee Related JP6978553B2 (ja) 2007-05-10 2020-07-17 心臓障害を検出するための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010507486A Expired - Fee Related JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016166494A Expired - Fee Related JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法
JP2018193389A Withdrawn JP2019010123A (ja) 2007-05-10 2018-10-12 心臓障害を検出するための方法
JP2020122926A Expired - Fee Related JP6978553B2 (ja) 2007-05-10 2020-07-17 心臓障害を検出するための方法

Country Status (11)

Country Link
US (5) US8628929B2 (https=)
EP (1) EP2153228A4 (https=)
JP (5) JP5749490B2 (https=)
CN (2) CN101743474B (https=)
AU (1) AU2008251822B2 (https=)
BR (1) BRPI0810631A2 (https=)
CA (2) CA2686959C (https=)
IN (1) IN2014MN01227A (https=)
MX (2) MX348082B (https=)
RU (1) RU2498309C2 (https=)
WO (1) WO2008140814A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0810631A2 (pt) * 2007-05-10 2017-05-09 Acorda Therapeutics Inc métodos para detecção de dano cardíaco
EP3777878A1 (en) 2008-08-15 2021-02-17 Acorda Therapeutics, Inc. Compositions and methods for treatment during non-acute periods following cns neurological injury
US9198952B2 (en) 2008-09-22 2015-12-01 The Brigham And Women's Hospital, Inc. Compositions of and methods of using ligand dimers
EP2370458B1 (en) * 2008-11-28 2014-10-15 Zensun (Shanghai) Science and Technology Limited Neuregulin peptides and their use
US8835120B2 (en) * 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
WO2011119836A1 (en) * 2010-03-24 2011-09-29 Massachusetts Institute Of Technology Methods and compositions for cardioprotection and cardioregeneration
CN108387744A (zh) * 2010-08-26 2018-08-10 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
RU2585391C1 (ru) * 2014-12-19 2016-05-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Чеченский государственный университет Способ иммунологического прогнозирования малых повреждений миокарда
WO2017053794A1 (en) * 2015-09-25 2017-03-30 Sawyer Douglas B Methods for treating cardiac injury
RU2648529C1 (ru) * 2016-12-27 2018-03-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ оценки эффективности лекарственной терапии у взрослых пациентов с острой сердечной недостаточностью после операций на открытом сердце, получающих лечение методом экстракорпоральной мембранной оксигенации
RU2709458C2 (ru) * 2017-12-22 2019-12-18 Марина Александровна Чичкова Способ оптимизации ранней иммунологической диагностики осложнений чрескожного коронарного вмешательства у пациентов с ИБС
RU2722111C1 (ru) * 2019-12-30 2020-05-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ ведения пациентов с хроническим лимфолейкозом в процессе полихимиотерапии по схеме fcr, направленный на предотвращение кардиотоксичности
RU2749552C1 (ru) * 2020-08-03 2021-06-15 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ отбора пациентов с длительно персистирующей формой фибрилляции предсердий на проведение эффективного катетерного лечения
RU2760242C1 (ru) * 2021-03-01 2021-11-23 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени В.А. Алмазова" Министерства здравоохранения Российской Федерации Способ оценки повреждения миокарда и риска развития осложнений после операций на сердце в условиях искусственного кровообращения
CN113238060B (zh) * 2021-05-08 2022-10-11 迈克生物股份有限公司 用于预测或诊断心肌炎的试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US5324502A (en) 1992-04-02 1994-06-28 Purdue Research Foundation Radiopharmaceuticals for imaging the heart
US6092695A (en) 1992-05-11 2000-07-25 Cytologix Corporation Interchangeable liquid dispensing cartridge pump
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
US6653249B1 (en) * 2000-05-25 2003-11-25 Penn Emblem Corporation Emblem having calendered fabric layer
GB0029154D0 (en) * 2000-11-30 2001-01-17 Lee Helen Signal enhancement with multiple labelled-antibodies
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
CN1267590C (zh) * 2004-06-11 2006-08-02 清华大学 一种用于组织修复的生长因子缓释体系的制备方法
CN1715926B (zh) * 2004-07-02 2011-08-17 上海泽生科技开发有限公司 神经调节蛋白突变体的应用
WO2007011757A1 (en) 2005-07-14 2007-01-25 Myogen, Inc. Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
US7776817B2 (en) 2005-09-02 2010-08-17 Morehouse School Of Medicine Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
BRPI0810631A2 (pt) 2007-05-10 2017-05-09 Acorda Therapeutics Inc métodos para detecção de dano cardíaco
DE102007061117A1 (de) 2007-12-19 2009-06-25 Robert Bosch Gmbh Elektrische Kontaktierung
EP2603221A4 (en) 2010-08-13 2014-02-26 Univ Georgetown GGF2 AND METHOD FOR ITS APPLICATION

Similar Documents

Publication Publication Date Title
JP2014122923A5 (https=)
JP2020176138A5 (https=)
RU2009145695A (ru) Способы выявления сердечных нарушений
Caldeira et al. Extracellular matrix constitution and function for tissue regeneration and repair
EP4552696A3 (en) Methods for predicting drug responsiveness in cancer patients
AR085837A1 (es) Metodo para evaluar la eficacia de una terapia para tratar la enfermedad de alzheimer
Park et al. Exercise therapy for an older patient with left ventricular assist device
RU2592148C1 (ru) Способ прогнозирования риска развития фибрилляции предсердий после коронарного шунтирования у пациентов с ишемической болезнью сердца
Choi et al. Characteristics of hypertension subtypes and treatment outcome among elderly Korean hypertensives
JCS Joint Working Group Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010)–Digest Version–
Chen et al. Response to Letter Regarding Article,“Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study”
Miyata et al. Effects of Valsartan on Fibrinolysis in Hypertensive Patients With Metabolic Syndrome–The KACT-MetS Study–
Bokhonovich et al. Results of Examinations of Patients with a History of Syphilis
RU2009100514A (ru) Способ контроля результатов редукции полости левого предсердия
Miyoshi et al. Low number of circulating CD34 positive cell is associated with greater progression of coronary calcium determined by MDCT
Gouweleeuw et al. The role of Neutrophil Gelatinase Associated Lipocalin in linking Depression and Heart Failure.
RU2015106402A (ru) Способ оценки эффективности контроля частоты желудочковых сокращений у больных постоянной формой фибрилляции предсердий
Park et al. A60 LUNG FIBROSIS: ANIMAL MODELS I: Interleukin-33 Promotes Production Of Tgf-B1 In Lung Fibroblast And Neutralization Of The Il-33 Ameliorates Bleomycin Induced Experimental Lung Injury/fibrosis
Guofeng et al. With the winding hole treatment of vascular dementia clinical curative effect and the influence of homocysteine
Kuznetsov et al. Worldwide geographic differences of patients selected for cardiac resynchronization therapy
Williams Abcg2 and Division of Cardiac Stem Cells (p 27)
Komorowska-Jagielska et al. THE ASSESSMENT OF CARDIOVASCULAR RISK USING QRISK2 PROCAM SCORE RCRI SCALES IN RENAL TRANSPLANT RECIPIENTS
Ottens et al. The effect of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial: 7AP5-1
Wojciak-Stothard Role of Rho GTPases in the regulation of pulmonary endothelial barrier function and angiogenesis
Staff UAB awarded $9.7 million to find treatments for deadly lung disease